NASH - Nonalcoholic Steatohepatitis Recruiting Phase 2 Trials for VK-2809 (DB15137)

IndicationStatusPhase
DBCOND0088313 (NASH - Nonalcoholic Steatohepatitis)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04173065A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASHTreatment